Evidence map›Paper›PMID 25415384›Full record

ArticleJournal of addictive diseases2015

Mortality, causes of death, and health status among methamphetamine users.

Diane M Herbeck, Mary-Lynn Brecht, Katherine Lovinger

Abstract read
In one paragraph

Article in Journal of addictive diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Features and Outcomes of Methamphetamine-associated Pulmonary Arterial Hypertension.American journal of respiratory and critical care medicine · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Diane M Herbecka Integrated Substance Abuse Programs, Semel Institute for Neuroscience and Human Behavior, University of California , Los Angeles , California , USA.
Mary-Lynn Brecht
Katherine Lovinger

Funding

Methamphetamine Abuse: Long-Term Trajectories, Correlates, Treatment EffectsR01DA025113 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BRECHT, MARY-LYNN · 2009 to 2012
$2.3M
NIDA NIH HHS DA025113NIDA NIH HHS R01 DA025113
6 · The paper itself

Abstract

This study examines causes of death, years of life lost, and health and drug use characteristics associated with mortality over an 8 to 10 year period in a sample of methamphetamine users who had and had not received substance use disorder treatment (N = 563). Decedents reported initiating their methamphetamine use for different reasons than surviving methamphetamine users, and some of these differences varied by treatment status. Study findings provide additional detail on long-term health and mortality outcomes in a diverse sample of methamphetamine users, which may inform public health strategies targeting the comparable and divergent needs of treated and untreated populations.

Indexed as

MethamphetamineAdultAmphetamine-Related DisordersCause of DeathDiagnosis, Dual (Psychiatry)FemaleHealth StatusHumansInterviews as TopicLongitudinal StudiesMaleMental DisordersMiddle AgedRisk FactorsSubstance Abuse Treatment CentersUnited StatesMethamphetamineMethamphetaminemorbiditymortalitysubstance use disorder treatment

Identifiers

PMID25415384
PMCPMC4684255

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.